Morgan Stanley »

Crescent Biopharma shares owned by Morgan Stanley

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2025-06-30 $248k 15k 16.14

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Morgan Stanley

Top funds holding Crescent Biopharma

FMR
Fairmount Funds Management
VR Adviser
BVF
Tang Capital Management
Vanguard Group
Logos Global Management
Deep Track Capital
Boxer Capital Management
Perceptive Advisors
Commodore Capital
Driehaus Capital Management
Frazier Life Sciences Management
Adage Capital Partners GP
Soleus Capital Management

View all funds holding Crescent Biopharma